TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) has a beta value of -0.13 and has seen 1.01 million shares traded in the recent trading session. The company, currently valued at $0.23M, closed the recent trade at $0.47 per share which meant it lost -$0.05 on the day or -10.67% during that session. The TCBP stock price is -5465.96% off its 52-week high price of $26.16 and 25.53% above the 52-week low of $0.35. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.19 million shares traded. The 3-month trading volume is 2.26 million shares.
TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information
Sporting -10.67% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TCBP stock price touched $0.47 or saw a rise of 42.69%. Year-to-date, TC BioPharm (Holdings) plc ADR shares have moved -9.59%, while the 5-day performance has seen it change -17.87%. Over the past 30 days, the shares of TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) have changed -8.15%. Short interest in the company has seen 38332.0 shares shorted with days to cover at 0.02.
TC BioPharm (Holdings) plc ADR (TCBP) estimates and forecasts
Figures show that TC BioPharm (Holdings) plc ADR shares have outperformed across the wider relevant industry. The company’s shares have lost -92.97% over the past 6 months, with this year growth rate of 100.00%, compared to 16.90% for the industry. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 45.82% over the past 5 years.
TCBP Dividends
TC BioPharm (Holdings) plc ADR is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s Major holders
Insiders own 0.01% of the company shares, while shares held by institutions stand at 7.01% with a share float percentage of 7.02%. Investors are also buoyed by the number of investors in a company, with TC BioPharm (Holdings) plc ADR having a total of 9.0 institutions that hold shares in the company.
